Trial OKed for Rare Disease Gene Therapy

A start-up biotech company says it received clearance from the Food and Drug Administration to begin a clinical trial of its gene therapy for Krabbe disease. Forge Biologics Inc. in Columbus, Ohio says FDA approved the company’s investigational new drug application, or IND, that in effect allows for trials with patients. Read In Full: https://sciencebusiness.technewslit.com/?p=40642